Eric J. Morinello

476 total citations
17 papers, 376 citations indexed

About

Eric J. Morinello is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Molecular Biology. According to data from OpenAlex, Eric J. Morinello has authored 17 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Health, Toxicology and Mutagenesis, 8 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Eric J. Morinello's work include Carcinogens and Genotoxicity Assessment (8 papers), Effects and risks of endocrine disrupting chemicals (6 papers) and Hedgehog Signaling Pathway Studies (3 papers). Eric J. Morinello is often cited by papers focused on Carcinogens and Genotoxicity Assessment (8 papers), Effects and risks of endocrine disrupting chemicals (6 papers) and Hedgehog Signaling Pathway Studies (3 papers). Eric J. Morinello collaborates with scholars based in United States, Germany and United Kingdom. Eric J. Morinello's co-authors include James A. Swenberg, Asoka Ranasinghe, Amy‐Joan L. Ham, Patricia B. Upton, Joel P. Bercu, Jun Nakamura, Patricia A. Weideman, Hasan Koç, R. Sangaiah and Ronald A. Herbert and has published in prestigious journals such as Food and Chemical Toxicology, Chemical Research in Toxicology and Drug Metabolism and Disposition.

In The Last Decade

Eric J. Morinello

17 papers receiving 361 citations

Peers

Countries citing papers authored by Eric J. Morinello

Since Specialization

Citations

This map shows the geographic impact of Eric J. Morinello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric J. Morinello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric J. Morinello more than expected).

Fields of papers citing papers by Eric J. Morinello

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric J. Morinello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric J. Morinello. The network helps show where Eric J. Morinello may publish in the future.

Co-authorship network of co-authors of Eric J. Morinello

This figure shows the co-authorship network connecting the top 25 collaborators of Eric J. Morinello. A scholar is included among the top collaborators of Eric J. Morinello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric J. Morinello. Eric J. Morinello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Development of Duration-Based Non-Mutagenic Thresholds of Toxicological Concern (TTCs) Relevant to Parenteral Extractables and Leachables (E&Ls) 2022 ·PDA Journal of Pharmaceutical Science and Technology ·(unknown), Joel P. Bercu, Thomas H. Broschard, (unknown), Catrin Hasselgren, (unknown), (unknown), Jessica Graham, (unknown), (unknown), Daniel J. Lettiere, (unknown), (unknown), Eric J. Morinello, Wolfgang Muster, Elizabeth A. Martin, (unknown), Lee M. Nagao, (unknown)	7
2	Carcinogenicity assessment of the Hedgehog pathway inhibitor, vismodegib in Tg.rasH2 mice and Sprague-Dawley rats 2017 ·Regulatory Toxicology and Pharmacology ·Jinze Li, Eric J. Morinello, Thomas Larsen, (unknown), Ivor Caro, Stephen E. Gould, (unknown), (unknown), Noël Dybdal, Donna M. Dambach, Melissa M. Schutten	2
3	Using default methodologies to derive an acceptable daily exposure (ADE) 2016 ·Regulatory Toxicology and Pharmacology ·Ellen C. Faria, Joel P. Bercu, David G. Dolan, Eric J. Morinello, (unknown), (unknown), (unknown), Patricia A. Weideman	30
4	Point of departure (PoD) selection for the derivation of acceptable daily exposures (ADEs) for active pharmaceutical ingredients (APIs) 2016 ·Regulatory Toxicology and Pharmacology ·Joel P. Bercu, Eric J. Morinello, (unknown), (unknown), Patricia A. Weideman	32
5	Determination of GDC‐0980 (apitolisib), a small molecule dual phosphatidylinositide 3‐kinase/mammalian target of rapamycin inhibitor in dog plasma by LC‐MS/MS to support a GLP toxicology study 2015 ·Biomedical Chromatography ·(unknown), Laurent Salphati, Amy Kim, Eric J. Morinello, (unknown), Jodie Pang, (unknown), Min Meng, Scott Reuschel, Brian Dean	4
6	Embryofetal Development Study of Vismodegib, a Hedgehog Pathway Inhibitor, in Rats 2014 ·Birth Defects Research Part B Developmental and Reproductive Toxicology ·Eric J. Morinello, (unknown), (unknown), Petra Goelzer, Heinrich Bürgin	18
7	Interplay of Dissolution, Solubility, and Nonsink Permeation Determines the Oral Absorption of the Hedgehog Pathway Inhibitor GDC-0449 in Dogs: An Investigation Using Preclinical Studies and Physiologically Based Pharmacokinetic Modeling 2010 ·Drug Metabolism and Disposition ·Harvey Wong, Frank‐Peter Theil, Yong Cui, James C. Marsters, S. Cyrus Khojasteh, Laurent Vernillet, Hank La, (unknown), Hong Wang, Eric J. Morinello, Yuzhong Deng, Cornelis E. C. A. Hop	17
8	Oral Bioavailability of Polychlorinated Dibenzo-p-Dioxins/Dibenzofurans in Industrial Soils 2009 ·Human and Ecological Risk Assessment An International Journal ·Brent L. Finley, Kurt A. Fehling, (unknown), Eric J. Morinello	5
9	Absence of toxic effects in F344/N rats and B6C3F1 mice following subchronic administration of chromium picolinate monohydrate 2004 ·Food and Chemical Toxicology ·Melissa C. Rhodes, Charles Hébert, Ronald A. Herbert, Eric J. Morinello, Joseph H. Roycroft, Greg Travlos, Kamal M. Abdo	34
10	The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzene 2003 ·Regulatory Toxicology and Pharmacology ·Richard J. Albertini, Harvey J. Clewell, Matthew W. Himmelstein, Eric J. Morinello, Stephen S. Olin, R. Julian Preston, (unknown), Martyn T. Smith, James A. Swenberg, Raymond R. Tice, Curtis C. Travis	35
11	Linking Pharmacokinetics and Biomarker Data to Mechanism of Action in Risk Assessment 2002 ·Human and Ecological Risk Assessment An International Journal ·James A. Swenberg, (unknown), Amy‐Joan L. Ham, Hasan Koç, Eric J. Morinello, Asoka Ranasinghe, Patricia B. Upton, Vernon E. Walker	3
12	Molecular dosimetry and repair of N(2),3-ethenoguanine in rats exposed to vinyl chloride. 2002 ·PubMed ·Eric J. Morinello, Amy‐Joan L. Ham, Asoka Ranasinghe, Jun Nakamura, Patricia B. Upton, James A. Swenberg	32
13	Differential induction of N(2),3-ethenoguanine in rat brain and liver after exposure to vinyl chloride. 2002 ·PubMed ·Eric J. Morinello, Hasan Koç, Asoka Ranasinghe, James A. Swenberg	19
14	Simultaneous Quantitation of N²,3-Ethenoguanine and 1,N²-Ethenoguanine with an Immunoaffinity/Gas Chromatography/High-Resolution Mass Spectrometry Assay 2001 ·Chemical Research in Toxicology ·Eric J. Morinello, Amy‐Joan L. Ham, Asoka Ranasinghe, R. Sangaiah, James A. Swenberg	43
15	DNA adducts: effects of low exposure to ethylene oxide, vinyl chloride and butadiene 2000 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·James A. Swenberg, Amy‐Joan L. Ham, Hasan Koç, Eric J. Morinello, Asoka Ranasinghe, Natalia Tretyakova, Patricia B. Upton, Kuen‐Yuh Wu	38
16	Formation and repair of DNA adducts in vinyl chloride- and vinyl fluoride-induced carcinogenesis. 1999 ·PubMed ·James A. Swenberg, Matthew S. Bogdanffy, Amy‐Joan L. Ham, (unknown), (unknown), Eric J. Morinello, Asoka Ranasinghe, (unknown), Patricia B. Upton	25
17	Immunoaffinity/Gas Chromatography/High-Resolution Mass Spectrometry Method for the Detection of N²,3-Ethenoguanine 1999 ·Chemical Research in Toxicology ·Amy‐Joan L. Ham, Asoka Ranasinghe, Eric J. Morinello, Jun Nakamura, Patricia B. Upton, Francis Johnson, James A. Swenberg	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact